Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) have received a consensus recommendation of “Reduce” from the fourteen brokerages that are presently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $14.25.
A number of research firms have recently issued reports on XRAY. Zacks Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, January 21st. Stifel Nicolaus set a $13.00 price target on DENTSPLY SIRONA in a research note on Thursday, November 6th. Barclays started coverage on DENTSPLY SIRONA in a research note on Monday, December 8th. They issued an “underweight” rating and a $12.00 price objective for the company. Finally, Robert W. Baird decreased their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 16th.
Check Out Our Latest Stock Report on DENTSPLY SIRONA
Insider Buying and Selling at DENTSPLY SIRONA
Hedge Funds Weigh In On DENTSPLY SIRONA
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Trust & Banking Corp lifted its position in shares of DENTSPLY SIRONA by 1,836.7% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock worth $1,344,000 after buying an additional 100,468 shares during the last quarter. Bank of Montreal Can raised its stake in DENTSPLY SIRONA by 8.2% during the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock worth $5,598,000 after acquiring an additional 26,610 shares in the last quarter. Commonwealth Equity Services LLC raised its stake in DENTSPLY SIRONA by 38.4% during the 3rd quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after acquiring an additional 223,339 shares in the last quarter. CWM LLC lifted its position in DENTSPLY SIRONA by 84.3% in the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after acquiring an additional 192,373 shares during the last quarter. Finally, Allianz Asset Management GmbH boosted its stake in DENTSPLY SIRONA by 63.6% in the third quarter. Allianz Asset Management GmbH now owns 1,355,643 shares of the medical instruments supplier’s stock valued at $17,203,000 after acquiring an additional 526,973 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.
DENTSPLY SIRONA Stock Performance
NASDAQ XRAY opened at $12.49 on Friday. The stock has a fifty day simple moving average of $12.20 and a 200-day simple moving average of $12.50. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. The stock has a market cap of $2.49 billion, a PE ratio of -2.83, a P/E/G ratio of 0.98 and a beta of 1.01. DENTSPLY SIRONA has a twelve month low of $9.85 and a twelve month high of $19.27.
DENTSPLY SIRONA Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.48%.
DENTSPLY SIRONA Company Profile
Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
